Cynthia Matossian, MD, FACS, ABES


Cataract predictability: Screen and treat unstable tear film in weeks

With a few key steps, surgeons can avert potential refractive surprises, and reduce postoperative dry eye for patients.

Blog: Artificial tear therapy for dry eye disease not quite as simple as it seems

Cynthia Matossian, MD, FACS, ABES, explains why eye care professionals should oversee the selection and use of artificial tears for patients with dry eye.

The latest on MGD reimbursements: LipiFlow and TearCare are still out-of-pocket procedures

Cynthia Matossian, MD, FACS, ABES, points out that there has been confusing news lately about what is (and is not) covered by Medicare when it comes to in-office treatments for meibomian gland dysfunction.

Advocating to MACs on behalf of your patients

November 06, 2021

In light of newly published fee schedules that include low payment rates for LipiFlow, Cynthia Matossian, MD, FACS, ABES, advises on how eyecare professionals should advocate for their patients and practices.